Pnc Financial Services Group, Inc. Igm Biosciences, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $190 Billion
- Q1 2025
A detailed history of Pnc Financial Services Group, Inc. transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 854 shares of IGMS stock, worth $1,041. This represents 0.0% of its overall portfolio holdings.
Number of Shares
854
Previous 23
3613.04%
Holding current value
$1,041
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding IGMS
# of Institutions
82Shares Held
16.2MCall Options Held
26.8KPut Options Held
800-
Baker Bros. Advisors LP New York, NY4.1MShares$5 Million0.06% of portfolio
-
Siren, L.L.C. New York, NY3.26MShares$3.97 Million0.21% of portfolio
-
Redmile Group, LLC San Francisco, CA2.95MShares$3.6 Million0.36% of portfolio
-
Black Rock Inc. New York, NY883KShares$1.08 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA876KShares$1.07 Million0.0% of portfolio
About IGM Biosciences, Inc.
- Ticker IGMS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,969,000
- Market Cap $35.3M
- Description
- IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...